Cost-effectiveness, cost-utility and the budget impact of antidepressants versus preventive cognitive therapy with or without tapering of antidepressants

Cost-effectiveness, cost-utility and the budget impact of antidepressants versus preventive cognitive therapy with or without tapering of antidepressants

BackgroundAs depression has a recurrent course, relapse and recurrence prevention is essential.AimsIn our randomised controlled trial (registered with the Nederlands trial register, identifier: NTR1907), we found that adding preventive cognitive therapy (PCT) to maintenance antidepressants (PCT+AD)...

Full description

Bibliographic Details
Main Authors: Nicola S. Klein, Ben F. M. Wijnen, Joran Lokkerbol, Erik Buskens, Hermien J. Elgersma, Gerard D. van Rijsbergen, Christien Slofstra, Johan Ormel, Jack Dekker, Peter J. de Jong, Willem A. Nolen, Aart H. Schene, Steven D. Hollon, Huibert Burger, Claudi L. H. Bockting
Format: Article
Language:English
Published: Cambridge University Press 2019-01-01
Series:BJPsych Open
Subjects:
Depressive disorders
antidepressants
cognitive behavioural therapies
cost-effectiveness
economics
Online Access:https://www.cambridge.org/core/product/identifier/S2056472418000819/type/journal_article

Internet

https://www.cambridge.org/core/product/identifier/S2056472418000819/type/journal_article

Similar Items